BIO-TECHNE CORP. DL-,01/ US09073M1045 /
| 2024-11-07 8:08:18 AM | Chg. -3.00 | Volume | Bid8:58:42 PM | Ask8:58:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 70.00EUR | -4.11% | 0 Turnover: 0.00 |
70.50Bid Size: 150 | 71.00Ask Size: 140 | 11.31 bill.EUR | - | - |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 117.1200 | 129.7490 | 132.3620 | 135.1240 | 145.3480 | ||||||
| Intangible Assets | 108.7760 | 292.8390 | 303.1240 | 452.0420 | 446.3320 | ||||||
| Long-Term Investments | 3.5750 | 0.0000 | - | - | - | ||||||
| Fixed Assets | 393.0780 | 815.0770 | 875.6900 | 1,210.1940 | 1,194.8360 | ||||||
| Inventories | 38.8470 | 49.5770 | 57.1020 | 60.1510 | 85.6480 | ||||||
| Accounts Receivable | 47.8740 | 70.0340 | 93.3930 | 116.8300 | 120.2960 | ||||||
| Cash and Cash Equivalents | 318.5680 | 54.5320 | 64.2370 | 91.6120 | 121.9900 | ||||||
| Current Assets | 469.4130 | 248.2830 | 253.8910 | 348.0250 | 398.3660 | ||||||
| Total Assets | 862.4910 | 1,063.3600 | 1,129.5810 | 1,558.2190 | 1,593.2020 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.6520 | 13.4430 | 20.6530 | 16.8560 | 18.4520 | ||||||
| Long-term debt | 6.9970 | 73 | 91.5000 | 343.7710 | 339 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 33.8000 | 61.4000 | 62.8000 | 120.6000 | 86.3000 | ||||||
| Liabilities | 67.2260 | 216.4250 | 250.3010 | 608.5920 | 514.1410 | ||||||
| Share Capital | 1.4800 | 1.4840 | 1.4880 | 1.4960 | 1.5040 | ||||||
| Total Equity | 795.2650 | 846.9350 | 879.2800 | 949.6270 | 1,079.0610 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 862.4910 | 1,063.3600 | 1,129.5810 | 1,558.2190 | 1,593.2020 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 357.7630 | 452.2460 | 499.0230 | 563.0030 | 642.9930 | ||||||
| Depreciation (total) | 19.1750 | 37.2260 | 42.7640 | 60.0360 | 64.4630 | ||||||
| Operating Result | 159.7500 | .1470 | 150.5930 | 120.5840 | 136.1780 | ||||||
| Interest Income | 2.6840 | -.9100 | -1.4990 | -7.0570 | -9.7790 | ||||||
| Income Before Taxes | 161.3920 | 154.1620 | 147.4810 | 111.9610 | 125.9520 | ||||||
| Income Taxes | 50.4440 | 46.4270 | 43.0050 | 35.8750 | -.1980 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 110.9480 | 107.7350 | 104.4760 | 76.0860 | 126.1500 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 136.7620 | 139.3590 | 143.8700 | 143.4480 | 170.3670 | ||||||
| Cash Flow from Investing Activities | 49.6880 | -426.4930 | -107.5700 | -305.9540 | -38.7120 | ||||||
| Cash Flow from Financing | -36.8060 | 31.2760 | -23.0830 | 189.3860 | -99.1880 | ||||||
| Decrease / Increase in Cash | 154.7820 | -264.0360 | 9.7050 | 27.3750 | 30.3780 | ||||||
| Employees | 967 | 1,356 | 1,560 | 1,800 | 2,000 | ||||||
